Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy; First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Antonio Di Sabatino studies several important gastrointestinal conditions, including autoimmune gastritis, ulcerative colitis, and different types of cancers connected to gastrointestinal issues such as intestinal lymphomas and small bowel adenocarcinoma. He also looks at how conditions like irritable bowel syndrome (IBS) can be affected by other health factors, such as allergies or a previous COVID-19 infection. His research often focuses on how to better prepare patients for procedures like colonoscopies and improve treatment plans based on specific patient profiles and conditions.
Key findings
In a study of 1,240 patients with autoimmune gastritis, 2.9% developed gastric adenocarcinomas and 10.6% developed neuroendocrine tumors, with age and gastrin levels significantly affecting risks.
Among 379 patients with ulcerative colitis, 90.5% had adequate bowel preparation for colonoscopy, with 1L-PEG-ASC showing a higher cleanliness score (8 out of 9) compared to 2L-PEG (6 out of 9).
B-cell intestinal lymphomas were associated with a median survival of 56 months, five times better than the 12 months for T-cell lymphomas, emphasizing the need for tailored treatment approaches.
In patients with small bowel adenocarcinoma, 11.5% had a mismatch repair deficiency, highlighting the importance of testing for biomarkers to improve treatment options.
In a study of 623 patients, symptoms like breathing difficulties and acid reflux significantly increased the risk of developing IBS after COVID-19, with some symptoms raising the risk by up to 3.5 times.
Frequently asked questions
Does Dr. Di Sabatino study autoimmune gastritis?
Yes, Dr. Di Sabatino conducts research on autoimmune gastritis, exploring its clinical profile and associated cancer risks.
What are the main conditions Dr. Di Sabatino focuses on?
He focuses on autoimmune gastritis, ulcerative colitis, various gastrointestinal cancers, and irritable bowel syndrome, especially in relation to COVID-19.
What treatments has Dr. Di Sabatino researched?
He has researched different bowel preparation techniques for colonoscopy, treatment effectiveness for inflammatory bowel disease, and personalized approaches for conditions like eosinophilic esophagitis.
Is Dr. Di Sabatino's work relevant to patients with bowel diseases?
Yes, his studies significantly benefit patients with bowel diseases by improving diagnosis, treatment strategies, and preparation for medical procedures.
How does seasonal allergy impact patients with IBS?
Dr. Di Sabatino's research found that allergens, such as grass pollen, can worsen symptoms in patients with irritable bowel syndrome, helping to tailor better management strategies.
Publications in plain English
Work Impairment in Patients with Celiac Disease and Its Relationship with Persistence of Symptoms, Dietary Adherence, Quality of Life, and Psychological Morbidity.
2026
Digestive diseases and sciences
Dota M, Rubbini L, Massetti G, Scarcella C, Maimaris S +6 more
Plain English This study looked at how celiac disease affects people’s ability to work and the reasons they miss work. Out of 167 patients, 14% missed work in the past month, averaging about 6.6 hours lost. Those who missed work experienced more ongoing symptoms, higher depression levels, and a lower quality of life compared to those who did not miss work, showing that persistent symptoms and being on a gluten-free diet for less than a year are key factors.
Who this helps: This information benefits patients with celiac disease and their doctors.
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study.
2026
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Maniero D, Ghisa M, Bruschi A, Lorenzon G, Bertin L +27 more
Plain English This study looked at how well orodispersible budesonide (BOTs) works for adults with eosinophilic esophagitis (EoE) in real-life situations. Researchers found that after 12 weeks of treatment, 84% of patients achieved deep remission, meaning their symptoms and inflammation significantly improved, and by one year, 78% of those who continued treatment maintained this success. The findings are important because they demonstrate that BOTs are effective and safe for managing EoE, with only mild side effects reported in 12% of patients.
Who this helps: This helps adult patients with eosinophilic esophagitis seeking effective treatment options.
The high prevalence of Whipple's disease in patients with inflammatory rheumatic diseases.
2026
Clinical and experimental rheumatology
Maimaris S, Germanò G, Torre A, Bianco C, Bianchi PI +13 more
Plain English This study looked at how common Whipple's disease (WD) is among patients with inflammatory rheumatic diseases. Out of over 23,000 patients, only 0.03% were diagnosed with WD, but among those suspected of having it, the prevalence jumped to nearly 16%, especially higher in males at around 24%. These findings highlight the need for doctors to be more aware of WD in rheumatology settings, which could help reduce delays in diagnosis and prevent the unnecessary use of treatments.
Who this helps: This helps doctors and patients who may experience unexplained symptoms.
Autoimmune gastritis: Diagnosis, clinical management and natural history. A position paper by the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO).
2026
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Lahner E, Lenti MV, Massironi S, Zingone F, Miceli E +6 more
Plain English This study focused on autoimmune atrophic gastritis (AAG), a condition where the immune system attacks the stomach lining, leading to problems like low stomach acid and difficulty absorbing important nutrients. The authors noted that many patients are often misdiagnosed or experience delays in their diagnosis, which can lead to serious health issues, including anemia and an increased risk of stomach cancer. Understanding AAG better is crucial for prompt diagnosis and better treatment, which can improve patients' health and reduce related healthcare costs.
Who this helps: This helps patients with autoimmune gastritis and their doctors.
Systematic high-calorie, high-protein oral nutritional support in hospitalized, moderately hypophagic patients at nutritional risk: A randomized-controlled trial.
2026
Clinical nutrition (Edinburgh, Scotland)
Cereda E, Borioli V, Caraccia M, Uggè A, De Simeis F +5 more
Plain English This study looked at how giving hospitalized adults high-protein nutritional supplements immediately upon their admission affected their recovery. Researchers found that those who received these supplements showed significant improvements: their body composition, muscle strength, and protein-calorie intake increased, and they spent two fewer days in the hospital compared to those who received the supplements later. This is important because it highlights how timely nutritional support can help patients recover faster and more effectively.
Who this helps: Patients at nutritional risk during hospitalization.
Plain English This study looked at how yoga therapy can help people with intestinal disorders like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). The findings showed that practicing yoga can improve symptoms, help manage stress, and enhance overall quality of life for these patients, making it a useful addition to traditional medical treatments. Yoga therapy offers a low-cost and low-risk option for improving health in people with these conditions.
Who this helps: This helps patients suffering from intestinal disorders and their healthcare providers.
Eosinophilic gastrointestinal disorders, a new epidemic.
2026
Current opinion in allergy and clinical immunology
Rossi CM, di Sabatino A
Plain English This study looked at eosinophilic gastrointestinal disorders (EGID), which are increasing in number and causing significant problems for patients. The researchers found that while eosinophilic esophagitis (EoE) has clear treatment options, non-EoE forms like eosinophilic gastritis and enteritis are less understood and not well-defined, making treatment more difficult. Understanding and improving treatment for these disorders is important because patients currently have limited options and may suffer from ongoing or worsening symptoms.
Who this helps: This helps patients with eosinophilic gastrointestinal disorders and their doctors.
DIAGNOSTIC YIELD AND USEFULNESS OF TERMINAL ILEAL INTUBATION IN ASYMPTOMATIC PATIENTS UNDERGOING COLONOSCOPY FOR COLORECTAL CANCER SCREENING OR POST-POLYPECTOMY SURVEILLANCE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
2026
Gastrointestinal endoscopy
Scalvini D, Maimaris S, Cappellini A, Lusetti F, Delogu C +12 more
Plain English The study looked at whether an additional procedure called terminal ileal intubation (TII) is useful during colonoscopies for people who don’t have any symptoms, specifically for colorectal cancer screening or after polyp removal. Researchers reviewed data from 11 studies involving over 25,000 patients and found that TII only detected important issues in 0.28% of cases and Crohn's disease in just 0.1% of cases, meaning it doesn’t significantly improve the chances of finding serious health problems. This matters because it suggests that doing TII for these patients is unnecessary and may just add time to the procedure without providing real benefits.
Who this helps: This helps doctors and patients by clarifying which procedures are necessary during colonoscopy.
Reproductive transitions and autoimmunity: implications for women's health in rheumatology and gastroenterology.
2026
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Cavagna L, Lenti MV, Cucinella L, Bottazzi F, Di Sabatino A +1 more
Plain English This study looked at how different stages of a woman's life, such as menstruation, pregnancy, and menopause, affect autoimmune diseases (conditions where the immune system attacks the body). The researchers found that these reproductive stages can change how autoimmune diseases develop and worsen, while these diseases can also affect a woman’s fertility and pregnancy experiences. The findings emphasize the need for better detection, care strategies, and support for women with autoimmune diseases at all stages of life to improve health outcomes for both mothers and their children.
Who this helps: This helps women with autoimmune diseases, healthcare providers, and their families.
Author's reply: "Anti-parietal cell antibodies are more prevalent and clinically relevant in autoimmune endocrine diseases: Comment on the ARIOSO position paper".
2026
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Lahner E, Lenti MV, Massironi S, Miceli E, Della Bella C +4 more
Clinical features and survival in primary intestinal lymphomas: A multicentre study.
2026
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Aronico N, Santacroce G, Lucioni M, Lenti MV, Bianchi PI +13 more
Plain English This study looked at two rare types of intestinal lymphomas, B-cell and T-cell, to understand their clinical features and survival rates. The researchers found that B-cell lymphomas are usually diagnosed earlier and patients live much longer, with a median follow-up showing a survival rate more than five times better than T-cell lymphomas (56 months for B-cell compared to only 12 months for T-cell). It’s important because understanding these differences can help doctors choose better treatments and care plans for patients.
Who this helps: This helps patients with intestinal lymphomas and their doctors.
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study.
2026
Diagnostics (Basel, Switzerland)
Scalvini D, Maimaris S, Stasi E, Valvano M, Brinch D +21 more
Plain English This study looked at how well patients with ulcerative colitis (UC) prepare their bowels for colonoscopies when their disease is under control, and compared two different bowel prep methods. Among 379 patients, 90.5% had adequate bowel preparation, but those using the 1L-PEG-ASC method scored better on cleanliness (8 out of 9) compared to those using 2L-PEG (6 out of 9) and had a higher exam completion rate (99.5% vs. 95.7%). This is important because it shows that even without active disease, good bowel prep is essential for effective cancer screenings, highlighting the benefits of using the 1L-PEG-ASC method for better results.
Who this helps: Patients with ulcerative colitis needing colonoscopies.
Novel insights into autoimmune gastritis: clinical profile and gastric neoplastic risk from an international multicentre study.
2026
Gut
Lenti MV, Miceli E, Soykan I, Riquelme A, Latorre G +40 more
Plain English This study looked at autoimmune gastritis (AIG) in 1,240 patients from different parts of the world, focusing on their health profiles and the risk of developing gastric cancer and neuroendocrine tumors. They found that 2.9% of patients developed gastric adenocarcinomas, while 10.6% developed neuroendocrine tumors; certain factors like being over 65 years old or having high gastrin levels significantly increased cancer risk. Understanding these regional differences in AIG and its risks can help doctors create better follow-up plans for patients.
Who this helps: This benefits patients with autoimmune gastritis and their healthcare providers.
European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption.
2025
United European gastroenterology journal
Lenti MV, Hammer HF, Tacheci I, Burgos R, Schneider S +25 more
Plain English This study discusses malabsorption, which occurs when the body struggles to absorb nutrients properly, affecting both children and adults. The consensus identified conditions that lead to malabsorption, like cystic fibrosis and coeliac disease, and emphasized the importance of early diagnosis through medical history and various tests; for example, 60% of malabsorption cases are linked to coeliac disease in patients with no apparent cause. Understanding malabsorption better helps healthcare providers create tailored treatment plans, improving patients' health outcomes.
Who this helps: Patients with malabsorption disorders.
BRCA2-Related Hereditary Cancer Syndrome-Associated Small Bowel Adenocarcinoma With Multiple BRCA2 Mutations: A Case Report and Review of the Literature.
2025
Cancer reports (Hoboken, N.J.)
Antoci F, Colella T, Biletta E, Travaglino E, De Lisi G +8 more
Plain English This study looked at a rare type of cancer called small bowel adenocarcinoma (SBA) in a 51-year-old woman who had previous breast cancer. The findings showed that her tumor had mutations in the BRCA2 gene, which is linked to hereditary cancer syndromes, making it important to recognize this connection for others diagnosed with SBA at a young age. This matters because understanding the genetic factors can help tailor treatment and screening options for patients with similar cancer histories.
Who this helps: This helps patients with small bowel cancer, especially those with a family history of breast cancer.
Rethinking the Use of Biologics in Inflammatory Bowel Disease Patients With Malignancy: Insights From the Treatment of Immune Checkpoint Inhibitor-Induced Colitis.
Expanded T cell clones with lymphoma driver somatic mutations accumulate in refractory celiac disease.
2025
Science translational medicine
Singh M, Louie RHY, Samir J, Field MA, Milthorpe C +26 more
Plain English This study looked at patients suffering from a severe form of celiac disease that doesn't improve with a gluten-free diet. Researchers found that in certain patients, immune cells called T cells had mutations linked to lymphoma, with 6 out of 10 patients showing these changes. This matters because it helps explain why some patients don’t respond to treatment and may lead to better understanding or management of their condition.
Who this helps: This helps patients with refractory celiac disease and their doctors.
Clinical and Endoscopic-Histological Features of Multifocal and Corpus-Restricted Atrophic Gastritis Patients With Non-Cardia Gastric Cancer or Dysplasia: A Multicenter, Cross-Sectional Study.
2025
Clinical and translational gastroenterology
Lahner E, Annibale B, Dilaghi E, Luciano Millado C, Lenti MV +25 more
Plain English This study examined two types of atrophic gastritis—multifocal (MF-AG) and corpus-restricted (CR-AG)—in patients who also had non-cardia gastric cancer (GC) or precancerous changes (dysplasia). Out of 84 patients, 56% had cancer, with similar rates observed in both types of atrophic gastritis. However, the cancer tended to appear more often as polyp-like growths in CR-AG patients, leading to more frequent surgeries compared to those with MF-AG.
Who this helps: This research benefits doctors managing patients at risk for gastric cancer.
Clinical Heterogeneity of Early-Onset Autoimmune Gastritis: From the Evidence to a Pediatric Tailored Algorithm.
2025
Diseases (Basel, Switzerland)
Taietti I, Votto M, Castagnoli R, Bertozzi M, De Filippo M +7 more
Plain English This study looked at autoimmune gastritis in children, a rare condition that causes stomach inflammation and can lead to serious health issues like anemia and an increased risk of stomach cancer. Two case studies were presented, including a 9-year-old girl with difficult-to-treat anemia and a 12-year-old boy initially misdiagnosed with another condition. The research emphasizes the need for doctors to consider autoimmune gastritis in children with ongoing stomach problems and the importance of proper diagnosis to prevent long-term complications.
Who this helps: This research benefits doctors who treat children with gastrointestinal symptoms.
Extended Focused Assessment with Sonography for Trauma in the Emergency Department: A Comprehensive Review.
2025
Journal of clinical medicine
Bella FM, Bonfichi A, Esposito C, Zanza C, Bellou A +5 more
Plain English This paper reviews how the Extended Focused Assessment with Sonography for Trauma (eFAST) is used in emergency departments to quickly check for serious injuries in trauma patients. The findings show that eFAST is effective at detecting dangerous conditions like internal bleeding and fluid around the heart, helping doctors make faster decisions that can save lives. Using eFAST helps ensure critical injuries are identified quickly, improving outcomes while using fewer resources in busy emergency settings.
Who this helps: This helps trauma patients by providing faster diagnosis and treatment in emergency situations.
Empowering the vulnerable in internal medicine: a narrative review on physical exercise as a tool to tackle frailty.
2025
Internal and emergency medicine
Lenti MV, Brera AS, Di Sabatino A, Corazza GR
Plain English This study looked at frailty, a condition often seen in older adults that leads to weakness and fatigue, making them more likely to get sick or die. Researchers found that regular physical exercise can help reduce or even reverse frailty, which is important because frail patients tend to have higher rates of hospitalization. By encouraging exercise, we can help older adults maintain their health and independence longer.
Who this helps: This benefits older patients at risk for frailty and their healthcare providers.
Correlates of Polypharmacy and Prescription Changes in Internal Medicine: a Prospective Five-Year Study.
2025
The American journal of medicine
Lenti MV, Frenna C, Brera AS, Di Sabatino A, Klersy C +1 more
Plain English This study looked at the use of multiple medications (called polypharmacy) in older patients at a hospital over five years. It found that 71.5% of patients were taking many medications when they were admitted, and this increased to 82.6% by the time they were discharged. The study revealed that older, frail patients with multiple health issues were more likely to be on many medications, which is linked to a higher chance of dying, highlighting the need for better ways to manage their medications.
Who this helps: This helps patients and doctors by emphasizing the importance of careful medication management for older adults.
Clinical and atopic features of patients with wheat allergy dependent on augmentation factors (WALDA) presenting with urticaria: a monocentric study.
2025
European annals of allergy and clinical immunology
Rossi CM, Merli S, Lenti MV, De Amici M, di Sabatino A
Plain English This study looked at patients with wheat allergy who also experience hives, a condition known as WALDA. Among the 11 patients studied, 73% had other allergic conditions like food or respiratory allergies, and 73% were also allergic to shrimp. This research is important because it helps doctors better understand the characteristics of patients with WALDA, enabling more effective diagnosis and treatment.
Who this helps: This helps patients with wheat allergies, especially those who experience hives.
Disrupted mucosal vascular barrier in eosinophilic esophagitis.
2025
Scientific reports
Lenti MV, Rossi CM, Cannizzaro R, Santacroce G, Lizier M +13 more
Plain English This study focused on how the blood vessels in the esophagus are affected in patients with eosinophilic esophagitis (EoE), a condition where the immune system causes inflammation in the esophagus. Researchers found that, in EoE patients, blood vessel barriers were leaking, while this was not the case in patients with reflux esophagitis or healthy individuals. In fact, levels of a specific marker for blood vessel integrity were significantly higher in EoE patients, showing that an active form of this condition disrupts the esophageal vascular barrier.
Who this helps: This information benefits patients with eosinophilic esophagitis and their doctors in understanding the condition better.
Minimum Inhibitory Concentration Increase inIsolates from Patients with Recurrence: Results from a Retrospective Single-Centre Cohort Study.
2025
Microorganisms
Valsecchi P, Asperges E, Corbella M, Banfi G, Maffezzoni M +10 more
Plain English This study looked at how resistant the bacteria causing C. difficile infections (CDI) are to certain antibiotics, focusing on patients who had recurring infections. Researchers tested samples from 108 patients and found that while there was no resistance to vancomycin, metronidazole, or tigecycline, all samples showed resistance to ciprofloxacin. Notably, 37.5% of the recurring cases had higher resistance levels (measured by MIC) for vancomycin and metronidazole, which was linked to a higher chance of dying within 28 days after infection.
Who this helps: This research benefits patients with C. difficile infections and helps doctors make better treatment decisions.
Serological assessment of PRO-C16 (type XVI collagen formation) reflects intestinal fibrostenotic strictures in patients with crohn's disease.
2025
BMC gastroenterology
Mortensen JH, Lindholm M, Langholm L, Giuffrida P, Ruane D +8 more
Plain English This research studied a potential blood marker called PRO-C16 to check for intestinal scarring in patients with Crohn's disease (CD). The study found that PRO-C16 levels were significantly higher in CD patients (especially those with strictures) compared to healthy individuals, with a notable ability to identify patients with strictures in two groups: 75% accuracy in the first group and 71% accuracy in the second group. This matters because having a reliable marker like PRO-C16 can help doctors better manage and treat patients with CD, potentially reducing the need for surgery.
Who this helps: Patients with Crohn's disease.
Immunological and clinical overlap between autoimmune gastritis and autoimmune liver diseases: a prospective cohort study.
2025
Frontiers in immunology
Massironi S, Dispinzieri G, Rossi A, Cristoferi L, Lenti MV +7 more
Plain English This study looked at how autoimmune gastritis (AIG) and autoimmune liver diseases (AILDs) often overlap in patients. Researchers found that 22.1% of patients with AILD tested positive for a specific antibody linked to AIG, with a median diagnosis age of 58. Among these positive cases, 91.3% were confirmed to have AIG, and many also had other autoimmune conditions like thyroiditis.
Who this helps: This research benefits patients with autoimmune liver diseases by promoting earlier diagnosis and better management of related gastric issues.
Pediatric autoimmune gastritis: An international, multicentric study.
2025
Journal of pediatric gastroenterology and nutrition
Lenti MV, Joudaki S, Miceli E, Lahner E, Massironi S +36 more
Plain English This study looked at how autoimmune gastritis (AIG) manifests in children under 18 years old. The researchers reviewed data from 51 patients and found that 92% had the most serious form of AIG, with a variety of related conditions like atopic dermatitis and asthma observed in some patients. Most notably, only one child had a Helicobacter pylori infection, which is often linked to stomach issues, suggesting a different cause for AIG in kids.
Who this helps: This information benefits pediatricians and healthcare providers by improving understanding and diagnosis of AIG in young patients.
Factors associated with comorbidity in hospitalized and non-hospitalized inflammatory bowel disease patients: A single-center, preliminary study.
2025
Journal of multimorbidity and comorbidity
Lenti MV, Brera AS, Broglio G, Bertolino G, Di Sabatino A +2 more
Plain English This study looked at the presence of other health issues (comorbidities) in patients with inflammatory bowel disease (IBD) who were either hospitalized or not. Out of 104 patients, 60.6% had comorbidities, with hospitalized patients being more affected (66.6% vs. 58.5% for outpatients). Factors like being older than 65, being female, having low income, and lower education levels were linked to higher chances of having multiple health issues, highlighting the need for targeted support for these patients.
Who this helps: This helps patients with IBD, particularly older individuals, women, and those with lower socioeconomic status.
Diagnostic Accuracy of Contrast-Enhanced Ultrasound Compared with Contrast-Enhanced Computed Tomography in the Follow-Up of Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
2025
Cancers
Gori G, Mazza S, Ciccioli C, Bartolotta E, Alfieri D +17 more
Plain English This study compared two imaging methods—contrast-enhanced ultrasound (CEUS) and contrast-enhanced computed tomography (CECT)—to see how well they detect changes in liver cancer (hepatocellular carcinoma) after treatment with radiofrequency ablation (RFA). The research involved 55 patients and found that CEUS correctly identified all complete responses to treatment, while CECT misclassified some, though both methods together detected almost all remaining tumors. This matters because CEUS is a reliable and cost-effective alternative to CECT, offering similar accuracy for patients with liver cancer.
Who this helps: Patients undergoing treatment for liver cancer.
A Novel Tool for Celiac Disease Classification Based on Clinical, Immunological and Genetic Markers.
2025
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Pala D, Naidu K, Lenti MV, Di Sabatino A, Nicora G
Plain English This study looked at a new tool designed to classify patients with Celiac Disease (CD) using various health markers, including symptoms, immune responses, and genetics. The researchers evaluated the tool on a group of nearly 2,500 patients and found it can effectively identify different subtypes of CD, which is crucial for timely treatment and avoiding serious health issues. Early and accurate classification can help prevent complications that arise from untreated CD, making it important for patient care.
Who this helps: This benefits patients with Celiac Disease and their doctors by improving diagnosis and treatment strategies.
Human Cytomegalovirus and Epstein-Barr Virus Infection in Inflammatory Bowel Disease: Crossing the Diagnostic Barrier for Appropriate Management.
2025
Biomedicines
Ciccocioppo R, Caldart F, Piralla A, Betti E, Frulloni L +2 more
Plain English This research studied how two common viruses, Human Cytomegalovirus and Epstein-Barr Virus, affect patients with Inflammatory Bowel Disease (IBD). The findings showed that using a specific blood test could accurately detect these viruses in IBD patients, helping doctors differentiate between a viral infection and a flare-up of IBD. This is important because it allows for better treatment decisions, potentially leading to improved outcomes for patients.
Who this helps: This helps patients with Inflammatory Bowel Disease by ensuring they receive the correct diagnosis and treatment.
Clinicopathological Correlates of Hormone Expression-Based Subtypes of Non-Functioning Duodenal/Ampullary Neuroendocrine Tumors: A Multicenter Study of 151 Cases.
2025
Endocrine pathology
Vanoli A, Piva N, Inzani FS, Grillo F, Klersy C +20 more
Plain English This study looked at different types of non-functioning duodenal neuroendocrine tumors (NF-Duo-NETs) and how the hormones they produce might relate to their behavior. Researchers analyzed 151 cases and found that the most common subtype was somatostatin-producing tumors (31%), which were larger and more aggressive compared to other types, with tumors often metastasizing to nearby tissues. Understanding these hormone profiles is important because they can help predict how aggressive a tumor may be, regardless of its size, which can guide treatment decisions.
Who this helps: This helps doctors better assess and treat patients with non-functioning duodenal neuroendocrine tumors.
HER2, HER3, and Mismatch Repair Protein Expression in Stage IV Small Bowel Adenocarcinoma: Results From a Multicenter Series.
2025
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Vanoli A, Colella T, Parente P, De Lisi G, Grillo F +16 more
Plain English This study looked at a rare form of cancer called stage IV small bowel adenocarcinoma (SBA) to see how certain proteins related to cancer treatment were expressed. They found that 11.5% of the tumors had a mismatch repair deficiency, 7.7% tested positive for HER2, and 40% had HER3 positivity, showing some differences in how these proteins appeared across tumors. These results are important because they highlight the need to check these biomarkers in SBA patients to improve treatment options, especially since there were differences between the primary tumors and their metastases.
Who this helps: Patients with stage IV small bowel adenocarcinoma.
Factors driving persistence to first-line advanced therapies in inflammatory bowel disease: a real-world study from a tertiary referral centre.
2025
Internal and emergency medicine
Lenti MV, Santacroce G, Lepore F, Mordà F, Lo Bello A +6 more
Plain English This study looked at how long patients with inflammatory bowel disease (IBD) stick with their first-line advanced therapies, such as biologics and oral medications. Out of 274 patients observed, half (51.5%) continued their treatment, while 26% stopped due to ineffectiveness. The findings suggest that the type of Crohn's disease a patient has, how long they had the disease before starting therapy, and whether they also used certain medications can affect their likelihood of sticking with treatment.
Who this helps: This benefits patients with inflammatory bowel disease by highlighting the factors that can improve their treatment success.
Effect of seasonal exposure in aeroallergen-sensitised patients with irritable bowel syndrome-diarrhoea.
2025
Frontiers in allergy
Rossi CM, Lenti MV, Merli S, Fiorita M, Lo Bello A +5 more
Plain English This study looked at how pollen allergies affect people with irritable bowel syndrome that causes diarrhea (IBS-D). Researchers analyzed data from 61 IBS patients over a period of time and found that those allergic to grass experienced a worsening of their gastrointestinal symptoms during pollen season, with a significant increase in their symptom scores by an average of 3.4 points. This is important because it shows that seasonal allergies can make IBS-D symptoms worse, which can help in managing treatment for these patients.
Who this helps: Patients with IBS-D who have grass pollen allergies.
Latent class analysis identifies novel coeliac disease subgroups with distinctive clinical features: a multicentric study.
2025
European journal of internal medicine
Lenti MV, Pala D, Aronico N, Dagliati A, Bianchi PI +6 more
Plain English This study looked at different types of coeliac disease (CD) by analyzing the symptoms and clinical characteristics of 2,478 adult patients from 19 centers in Italy. Researchers identified four distinct subgroups of CD patients: those with mainly lower gastrointestinal symptoms, those with upper gastrointestinal issues, those who are mostly asymptomatic, and those with anemia and fatigue. They found that some patients might be misclassified under traditional criteria, suggesting that personalized approaches could improve diagnosis and treatment for CD.
Who this helps: This benefits patients with coeliac disease by potentially leading to better diagnosis and tailored treatments for their specific symptoms.
Different Survival Outcomes of Small Bowel Adenocarcinomas and T-Cell Lymphomas Associated With Celiac Disease.
2025
The American journal of gastroenterology
Santacroce G, Vanoli A, Aronico N, Bianchi PI, Lenti MV +11 more
Plain English This study looked at two types of serious cancers linked to celiac disease: small bowel adenocarcinoma (SBA) and T-cell lymphoma (TCL). Researchers found that patients with SBA had a much better chance of surviving than those with TCL, with survival rates significantly different between the two groups. Specifically, 70% of TCL patients did not respond to a gluten-free diet, while only one patient with SBA did not benefit from it. This research highlights the need for different approaches in treating these two cancer types.
Who this helps: This helps doctors and patients dealing with celiac disease and its associated cancers.
Italian EoExpert panel recommendation for disease control, switching criteria, and follow-up in eosinophilic esophagitis from pediatric to adult age.
2025
Therapeutic advances in gastroenterology
Vincenzo Savarino E, Fassan M, de Bortoli N, Romano C, Di Sabatino A +4 more
Plain English This research studied eosinophilic esophagitis (EoE), a chronic condition that affects the esophagus and can significantly harm patients' quality of life. The experts reviewed existing practices and developed new tools to better diagnose and manage EoE, which included the I.M.P.A.C.T. questionnaire for understanding patients' adaptive behaviors and the S.C.O.P.E. framework for evaluating treatment effectiveness. Their findings underline the necessity of prompt diagnosis and consistent management to prevent complications like strictures or food blockages.
Who this helps: This benefits patients with eosinophilic esophagitis and their healthcare providers.
A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting.
2025
European journal of gastroenterology & hepatology
Scalvini D, Bezzio C, Maimaris S, Lenti MV, Francesca L +18 more
Plain English In this study, researchers compared two types of bowel preparation methods, 1L-PEG-ASC and 2L-PEG, for patients with inflammatory bowel disease (IBD) undergoing outpatient colonoscopy. They found that 1L-PEG-ASC was more effective, with 89.8% of patients achieving adequate preparation compared to 83.8% with 2L-PEG. Additionally, factors like being male, having a history of specific surgeries, and having stricturing Crohn’s disease were linked to poorer preparation results.
Who this helps: This benefits patients with IBD who need effective bowel preparation before a colonoscopy.
Plain English This study examined how COVID-19 is linked to the development of irritable bowel syndrome (IBS) by looking at 623 patients over a year. Researchers found that symptoms like difficulty breathing, acid reflux, and hunger pains significantly increased the risk of developing IBS after COVID-19, with some symptoms affecting the risk as much as 3.5 times. Understanding these connections is important because it highlights specific symptoms that can signal a higher risk for IBS, allowing for better treatment and prevention strategies.
Who this helps: This helps patients recovering from COVID-19 who may experience digestive issues.